1163.1 - Testing for HER2 status in Gastric Cancer for access to trastuzumab

Page last updated: 13 July 2016

Application Detail

Status

Open

Description of Medical Service

In-situ hybridisation (ISH) for PBS listing of trastuzumab.

Description of Medical Condition

Previously untreated human epidermal growth factor receptor 2 (HER2) positive inoperable locally advanced or metastatic gastric or gastro-oesophageal cancer.

Reason for Application

New MBS item

Medical Service Type

Investigative

Previous Application Number

1163

Associated Documentation

Application Form

-

PICO Confirmation

Final Protocol (PDF 542 KB)
Final Protocol (Word 1319 KB)

Assessment Report

-

Public Summary Document

Public Summary Document (PDF 726 KB)
Public Summary Document (Word 90 KB)

Meetings for this Application

PASC

Please see Application 1163

ESC

11 to 12 June 2015

MSAC

30 to 31 July 2015